Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2025

Earnings Per Share [Abstract]

Schedule of Weighted-Average Common Shares Outstanding

The following securities are the weighted-average common shares outstanding used to calculate basic and diluted net loss per common share:

	Three Months Ended March 31,
	2025		2024
Common stock		45,928,793		32,432,524
May 2023 Tranche A pre-funded warrants		-		2,408,830
May 2023 Tranche B pre-funded warrants		-		451,632
October 2023 pre-funded warrants		250,000		915,385
Total		46,178,793		36,208,371

Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding for the periods presented because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares):

	As of March 31,
	2025		2024
Warrants issued to 2010/2012 convertible note    holders to purchase common stock		-		6,804
Warrants issued to underwriter to purchase common stock		-		1,100
March 2022 common warrants		516,265		1,809,068
May 2023 Tranche B warrants		870,628		6,600,000
Options to purchase common stock		3,406,719		3,102,856
Outstanding restricted stock units		361,991		299,280
Total		5,155,603		11,819,108